Sean Williams from Motleys put out an article yesterday ..Biotech is officially in a bear market. Is it time to panic?
http://www.snsanalytics.com/YQm7y6. Twitter address.
Boils down to the importance of investing in companies with profiits , diversified products and avoiding those that only hinge upon devices and the like still in trials.
As an AhZ holder i felt it indicated AHZ had, in the main, correct credentials to weather out the bear biotech market if it continues. However medical equipment sales and cardiocel would be the strength rather than the vaccinnes. But i have great optimism for the hpv and hsv vaccinness as well as the cardiocel and medical equipment sales in their pipeline for profitability.
Fox
high buy, page-76
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.22 |
Change
0.740(6.45%) |
Mkt cap ! $258.3M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $12.25 | $11.49 | $395.2K | 33.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $11.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.22 | 127 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |